News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
640,968 Results
Type
Article (61100)
Company Profile (70)
Press Release (579798)
Section
Business (173638)
Career Advice (2725)
Deals (32415)
Drug Delivery (95)
Drug Development (76845)
Employer Resources (149)
FDA (14905)
Job Trends (13864)
News (304760)
Policy (28903)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2883)
Academic (2)
Accelerated approval (3)
Adcomms (22)
Allergies (79)
Alliances (43076)
ALS (77)
Alzheimer's disease (1270)
Antibody-drug conjugate (ADC) (88)
Approvals (14902)
Artificial intelligence (225)
Autoimmune disease (13)
Automation (13)
Bankruptcy (290)
Best Places to Work (10853)
BIOSECURE Act (15)
Biosimilars (91)
Biotechnology (51)
Bladder cancer (53)
Brain cancer (25)
Breast cancer (235)
Cancer (1767)
Cardiovascular disease (129)
Career advice (2303)
Career pathing (31)
CAR-T (134)
Cell therapy (380)
Cervical cancer (15)
Clinical research (62056)
Collaboration (677)
Compensation (253)
Complete response letters (19)
COVID-19 (2560)
CRISPR (36)
C-suite (203)
Cystic fibrosis (97)
Data (1731)
Decentralized trials (2)
Denatured (24)
Depression (36)
Diabetes (212)
Diagnostics (6096)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (100)
Drug pricing (94)
Drug shortages (23)
Duchenne muscular dystrophy (64)
Earnings (59454)
Editorial (32)
Employer branding (18)
Employer resources (132)
Events (93471)
Executive appointments (637)
FDA (15904)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (643)
Gene editing (94)
Generative AI (19)
Gene therapy (256)
GLP-1 (623)
Government (4423)
Grass and pollen (4)
Guidances (45)
Healthcare (18186)
Huntington's disease (18)
IgA nephropathy (18)
Immunology and inflammation (83)
Indications (23)
Infectious disease (2671)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (73)
Interviews (525)
IPO (14765)
IRA (38)
Job creations (3414)
Job search strategy (1940)
Kidney cancer (9)
Labor market (23)
Layoffs (473)
Leadership (17)
Legal (6419)
Liver cancer (64)
Lung cancer (253)
Lymphoma (115)
Machine learning (2)
Management (53)
Manufacturing (228)
MASH (51)
Medical device (12591)
Medtech (12596)
Mergers & acquisitions (18119)
Metabolic disorders (547)
Multiple sclerosis (60)
NASH (13)
Neurodegenerative disease (67)
Neuropsychiatric disorders (22)
Neuroscience (1699)
NextGen: Class of 2025 (6374)
Non-profit (4312)
Northern California (2035)
Now hiring (11)
Obesity (291)
Opinion (223)
Ovarian cancer (57)
Pain (78)
Pancreatic cancer (69)
Parkinson's disease (119)
Partnered (17)
Patents (182)
Patient recruitment (86)
Peanut (49)
People (59214)
Pharmaceutical (21)
Pharmacy benefit managers (15)
Phase I (19524)
Phase II (27401)
Phase III (19979)
Pipeline (796)
Podcasts (50)
Policy (93)
Postmarket research (2470)
Preclinical (8256)
Press Release (67)
Prostate cancer (85)
Psychedelics (27)
Radiopharmaceuticals (246)
Rare diseases (325)
Real estate (5982)
Recruiting (61)
Regulatory (19863)
Reports (31)
Research institute (2392)
Resumes & cover letters (405)
Rett syndrome (3)
RNA editing (1)
RSV (31)
Schizophrenia (60)
Series A (114)
Series B (72)
Service/supplier (9)
Sickle cell disease (48)
Southern California (1801)
Special edition (10)
Sponsored (28)
Startups (3336)
State (1)
Stomach cancer (8)
Supply chain (45)
The Weekly (25)
United States (18283)
Vaccines (613)
Venture capitalists (29)
Webinars (12)
Weight loss (188)
Women's health (28)
Worklife (16)
Date
Today (108)
Last 7 days (584)
Last 30 days (2794)
Last 365 days (31412)
2025 (6083)
2024 (32284)
2023 (36352)
2022 (46636)
2021 (51598)
2020 (50749)
2019 (44779)
2018 (34081)
2017 (30741)
2016 (30083)
2015 (35459)
2014 (28393)
2013 (24991)
2012 (26249)
2011 (26487)
2010 (24949)
Location
Africa (870)
Alabama (49)
Alaska (6)
Arizona (157)
Arkansas (13)
Asia (37976)
Australia (7279)
California (4679)
Canada (1644)
China (391)
Colorado (220)
Connecticut (238)
Delaware (115)
Europe (87924)
Florida (718)
Georgia (174)
Idaho (56)
Illinois (479)
India (21)
Indiana (255)
Iowa (6)
Japan (121)
Kansas (90)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (746)
Massachusetts (3414)
Michigan (206)
Minnesota (303)
Mississippi (2)
Missouri (78)
Montana (29)
Nebraska (23)
Nevada (49)
New Hampshire (59)
New Jersey (1404)
New Mexico (29)
New York (1370)
North Carolina (877)
North Dakota (8)
Northern California (2035)
Ohio (171)
Oklahoma (14)
Oregon (35)
Pennsylvania (1050)
Puerto Rico (8)
Rhode Island (22)
South America (1173)
South Carolina (14)
South Dakota (1)
Southern California (1801)
Tennessee (82)
Texas (716)
Utah (152)
Virginia (118)
Washington D.C. (44)
Washington State (454)
West Virginia (3)
Wisconsin (50)
640,968 Results for "university of sydney".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CARTHERICS ENTERS AGREEMENTS WITH UNIQUEST, THE UNIVERSITY OF QUEENSLAND AND THE UNIVERSITY OF SYDNEY FOR ADVANCING INNOVATIVE CARDIAC CELLULAR THERAPY
July 25, 2024
·
4 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of SydneyExport of LaNeo MDMA Completes August 2022 Contract Fulfillment
PharmAla Biotech Holdings Inc. is pleased to announce the receipt of an export permit for the shipment of its allotment of GMP LaNeo MDMA to the University of Sydney.
June 16, 2023
·
8 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
BCAL DIAGNOSTICS OPENS NEW LABORATORY IN SYDNEY AS IT ACCELERATES DEVELOPMENT OF ITS BREAST CANCER BLOOD SCREENING TOOL
BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) an Australian-based biotechnology company announced the opening of its development and clinical service laboratory in Sydney.
May 4, 2023
·
3 min read
Press Releases
University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx
January 15, 2025
·
3 min read
Drug Development
ABVC BioPharma Vitargus® Phase II Study Received Ethical Approval at Sydney Eye Hospital in Australia
ABVC BioPharma, Inc. today announced that the Vitrargus® Phase II study at the Sydney Eye Hospital in New South Wales, Australia received ethical approval from the St. Vincent’s Hospital Melbourne Human Research Ethics Committee (HREC) on May 15, 2023.
May 22, 2023
·
3 min read
Press Releases
Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson’s Disease
February 20, 2025
·
5 min read
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules, is thrilled that – following pre-submission meetings held in Q1 of 2023 – it has received written guidance from the UK’s Medicines and Healthcare products Regulatory Agency’s.
July 20, 2023
·
8 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
1 of 64,097
Next
